691 related articles for article (PubMed ID: 11395417)
1. Synthesis and function of 3-phosphorylated inositol lipids.
Vanhaesebroeck B; Leevers SJ; Ahmadi K; Timms J; Katso R; Driscoll PC; Woscholski R; Parker PJ; Waterfield MD
Annu Rev Biochem; 2001; 70():535-602. PubMed ID: 11395417
[TBL] [Abstract][Full Text] [Related]
2. p85/p110-type phosphatidylinositol kinase phosphorylates not only the D-3, but also the D-4 position of the inositol ring.
Funaki M; Katagiri H; Kanda A; Anai M; Nawano M; Ogihara T; Inukai K; Fukushima Y; Ono H; Yazaki Y; Kikuchi M; Oka Y; Asano T
J Biol Chem; 1999 Jul; 274(31):22019-24. PubMed ID: 10419527
[TBL] [Abstract][Full Text] [Related]
3. Structural insight into substrate specificity and regulatory mechanisms of phosphoinositide 3-kinases.
Djordjevic S; Driscoll PC
Trends Biochem Sci; 2002 Aug; 27(8):426-32. PubMed ID: 12151228
[TBL] [Abstract][Full Text] [Related]
4. PTEN and myotubularin phosphoinositide phosphatases: bringing bioinformatics to the lab bench.
Wishart MJ; Taylor GS; Slama JT; Dixon JE
Curr Opin Cell Biol; 2001 Apr; 13(2):172-81. PubMed ID: 11248551
[TBL] [Abstract][Full Text] [Related]
5. Loss of PTEN expression does not contribute to PDK-1 activity and PKC activation-loop phosphorylation in Jurkat leukaemic T cells.
Freeley M; Park J; Yang KJ; Wange RL; Volkov Y; Kelleher D; Long A
Cell Signal; 2007 Dec; 19(12):2444-57. PubMed ID: 17826953
[TBL] [Abstract][Full Text] [Related]
6. Introduction: multifaceted roles of lipids and their catabolites in immune cell signaling.
Ott VL; Cambier JC
Semin Immunol; 2002 Feb; 14(1):1-6. PubMed ID: 11884225
[No Abstract] [Full Text] [Related]
7. Preferential killing of PTEN-null myelomas by PI3K inhibitors through Akt pathway.
Zhang J; Choi Y; Mavromatis B; Lichtenstein A; Li W
Oncogene; 2003 Sep; 22(40):6289-95. PubMed ID: 13679867
[TBL] [Abstract][Full Text] [Related]
8. Pharmacology of phosphoinositides, regulators of multiple cellular functions.
Balla T
Curr Pharm Des; 2001 Apr; 7(6):475-507. PubMed ID: 11281854
[TBL] [Abstract][Full Text] [Related]
9. A new selective AKT pharmacological inhibitor reduces resistance to chemotherapeutic drugs, TRAIL, all-trans-retinoic acid, and ionizing radiation of human leukemia cells.
Martelli AM; Tazzari PL; Tabellini G; Bortul R; Billi AM; Manzoli L; Ruggeri A; Conte R; Cocco L
Leukemia; 2003 Sep; 17(9):1794-805. PubMed ID: 12970779
[TBL] [Abstract][Full Text] [Related]
10. A role for the actin cytoskeleton in the hormonal and growth-factor-mediated activation of protein kinase B.
Peyrollier K; Hajduch E; Gray A; Litherland GJ; Prescott AR; Leslie NR; Hundal HS
Biochem J; 2000 Dec; 352 Pt 3(Pt 3):617-22. PubMed ID: 11104665
[TBL] [Abstract][Full Text] [Related]
11. Signalling through phosphoinositide 3-kinases: the lipids take centre stage.
Leevers SJ; Vanhaesebroeck B; Waterfield MD
Curr Opin Cell Biol; 1999 Apr; 11(2):219-25. PubMed ID: 10209156
[TBL] [Abstract][Full Text] [Related]
12. Insulin-induced Drosophila S6 kinase activation requires phosphoinositide 3-kinase and protein kinase B.
Lizcano JM; Alrubaie S; Kieloch A; Deak M; Leevers SJ; Alessi DR
Biochem J; 2003 Sep; 374(Pt 2):297-306. PubMed ID: 12841848
[TBL] [Abstract][Full Text] [Related]
13. Phosphoinositide signaling disorders in human diseases.
Pendaries C; Tronchère H; Plantavid M; Payrastre B
FEBS Lett; 2003 Jul; 546(1):25-31. PubMed ID: 12829232
[TBL] [Abstract][Full Text] [Related]
14. Structural determinants of phosphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin, and staurosporine.
Walker EH; Pacold ME; Perisic O; Stephens L; Hawkins PT; Wymann MP; Williams RL
Mol Cell; 2000 Oct; 6(4):909-19. PubMed ID: 11090628
[TBL] [Abstract][Full Text] [Related]
15. Phosphoinositide kinases.
Fruman DA; Meyers RE; Cantley LC
Annu Rev Biochem; 1998; 67():481-507. PubMed ID: 9759495
[TBL] [Abstract][Full Text] [Related]
16. PI 3-kinases and PTEN: how opposites chemoattract.
Comer FI; Parent CA
Cell; 2002 May; 109(5):541-4. PubMed ID: 12062096
[TBL] [Abstract][Full Text] [Related]
17. Phosphatidylinositol 3-kinase signaling controls levels of hypoxia-inducible factor 1.
Jiang BH; Jiang G; Zheng JZ; Lu Z; Hunter T; Vogt PK
Cell Growth Differ; 2001 Jul; 12(7):363-9. PubMed ID: 11457733
[TBL] [Abstract][Full Text] [Related]
18. PTEN and myotubularin phosphatases: from 3-phosphoinositide dephosphorylation to disease.
Wishart MJ; Dixon JE
Trends Cell Biol; 2002 Dec; 12(12):579-85. PubMed ID: 12495846
[TBL] [Abstract][Full Text] [Related]
19. PTEN expression causes feedback upregulation of insulin receptor substrate 2.
Simpson L; Li J; Liaw D; Hennessy I; Oliner J; Christians F; Parsons R
Mol Cell Biol; 2001 Jun; 21(12):3947-58. PubMed ID: 11359902
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and function of membrane phosphoinositides in budding yeast, Saccharomyces cerevisiae.
Strahl T; Thorner J
Biochim Biophys Acta; 2007 Mar; 1771(3):353-404. PubMed ID: 17382260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
